Related Experiment Video
Updated: May 31, 2026

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Cutaneous drug hypersensitivity: immunological and genetic perspective
Kisalay Ghosh1, Gautam Banerjee, Asok Kumar Ghosal
1Department of Dermatology, MGM Medical College and LSK Hospital, Kishanganj, Bihar, India.
Genetic factors influence unpredictable drug hypersensitivity reactions. Understanding genetic susceptibility, influenced by ethnicity and phenotype, can reduce severe cutaneous drug reactions.
Area of Science:
- Immunology
- Pharmacogenomics
- Human Genetics
Background:
- Drug hypersensitivity is an unpredictable, immune-mediated adverse drug reaction.
- Genetic predisposition plays a role in hypersensitivity.
- The "hapten concept" and "pharmacological interaction" hypotheses explain immune sensitization.
Purpose of the Study:
- To explore the genetic basis of drug hypersensitivity.
- To investigate the impact of genetic susceptibility on adverse drug reactions.
- To reduce morbidity and mortality associated with cutaneous drug hypersensitivity.
Main Methods:
- Utilized high-resolution genotyping after the Human Genome Project.
- Analyzed genetic susceptibility to drug hypersensitivity.
- Examined ethnicity and phenotype dependencies.
Main Results:
- Genetic susceptibility to drug hypersensitivity is proven.
- Trends in susceptibility are dependent on ethnicity and phenotype.
- Pharmacogenomic insights are advancing.
Conclusions:
- Genetic knowledge can mitigate drug hypersensitivity.
- Personalized medicine approaches can improve patient outcomes.
- Reduced morbidity and mortality from cutaneous drug hypersensitivity is achievable.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Allergic Drug Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics and Pharmacogenomics: Overview

